Agenus Inc. (AGEN) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agenus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.453 -- 00:00:05.422 Good afternoon, and welcome to Agenis, Inc.' 's investor briefing call. 00:00:05.422 -- 00:00:09.449 Currently, all participants are in a listen-only mode. 00:00:09.449 -- 00:00:13.456 A question-and-answer session will follow the formal remarks. 00:00:13.456 -- 00:00:15.900 As a reminder, this conference is being recorded. 00:00:15.900 -- 00:00:21.907 I will now turn the call over to Zach Arman, head of investor relations. 00:00:22.131 -- 00:00:26.390 Thank you, operator. Welcome to Agenis' investor briefing call. 00:00:26.390 -- 00:00:30.974 Earlier today, we issued a press release announcing a strategic collaboration between 00:00:30.974 -- 00:00:36.399 Agenis and Zytus Life Sciences, which we are here to review in more detail with you today. 00:00:36.399 -- 00:00:41.622 A copy of the press release is available on our website at www.investors.agenisbio.com. 00:00:43.986 -- 00:00:48.250 Before we begin, I'd like to remind everyone that today's discussion will include forward-looking 00:00:48.250 -- 00:00:52.774 statements. These statements are subject to risks and uncertainties, which may cause 00:00:52.774 -- 00:00:56.292 actual results to differ materially from expectations. 00:00:56.292 -- 00:00:59.995 Please refer to our SEC filings for further detail. 00:00:59.995 -- 00:01:03.679 Joining me today are Garrel Arman, Chairman and CEO, and Dr. 00:01:03.679 -- 00:01:10.245 Stephen O'Day, Chief Medical Officer. I'll now turn the call over to Garrel Arman. 00:01:10.245 -- 00:01:14.489 Thank you, Zach, and good afternoon, everyone. 00:01:14.489 -- 00:01:17.550 Thank you for joining us. 00:01:17.552 -- 00:01:22.756 On today's call, we will be discussing an exciting new partnership between Agenis 00:01:22.756 -- 00:01:24.693 Enzytis. ...